glp-1 kidney news outcomes today Receptor Agonist Use in Transplant Recipients in: Kidney Volume 17 Issue 8 (2025) GLP-1 receptor agonist versus DPP-4 – A new study from NYU

10.2337/diabetes.54.12.3458 9 BoseS

to treat obesity: Wegovy, Saxenda and Zepbound Emerging Marketplace Trends The GLP-1 market continues to be dynamic with five key emerging trends that employers and other stakeholders should consider, as they make actions that align with their coverage philosophy and population needs

GLP-1 agonists concept with syringe, body outline, and heart

Dispatch is discreet by default

This includes pharmaceutical-grade compound from a licensed 503A compounding pharmacy, medical oversight, a personalized dosing protocol, and monitoring

doi: 10.1111/j.1365-2249.2006.03295.x 89 HeoYJJooYBOhHJParkMKHeoYMChoMLet al